Evidence map›Paper›PMID 40717857›Full record

ArticleHeart rhythm O22025

Current practices in managing patients with cardiac implantable electronic devices: Results of an international survey.

James Allred, Amber Seiler, Mark Lyons, Paul Roberts, Angela Tsiperfal, Laura van Heel, Catherina Meijer, Emmanuelle Nicolle, David Lanctin, Eimo Martens

Abstract read
In one paragraph

Article in Heart rhythm O2, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. EHRA perspective on the digital data revolution in arrhythmia management: insights from the association's annual summit.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2025
    Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

James AllredCV Remote Solutions, Greensboro, North Carolina.
Amber SeilerCV Remote Solutions, Greensboro, North Carolina.
Mark LyonsCardiology and Physiology Department, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom.
Paul RobertsCardiology and Physiology Department, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.
Angela TsiperfalCardiac Electrophysiology Department, Stanford Health Care, Stanford, California.
Laura van HeelCV Remote Solutions, Greensboro, North Carolina.
Catherina MeijerHealth Economics and Outcomes Research Division, Deloitte, Brussels, Belgium.
Emmanuelle NicolleCardiac Rhythm Management, Medtronic, Mounds View, Minnesota.
David LanctinCardiac Rhythm Management, Medtronic, Mounds View, Minnesota.
Eimo MartensDevice Therapy and Telemedicine Department, Technical University of Munich, Munich, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Managing patients with cardiac implantable electronic devices (CIEDs) is increasingly complicated with expanding populations and evolving technologies. While the 2023 Heart Rhythm Society/European Heart Rhythm Association/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society consensus on management of remote device clinics provides recommendations, the adoption of these practices in real-world practice is unknown. Objective: This survey of device clinic staff characterized the adoption and variability of CIED follow-up practices. Methods: A Delphi panel composed of U.S. and European Union clinical experts guided the research objectives, structure, and content of the survey. Once consensus was reached, the online survey (Qualtrics) was deployed in partnership with HRS through e-mail, social media posts, and at the HRX conference. An available case analysis was performed to handle missing data. Results: A total of 471 responses were collected from 44 countries, including 310 in the United States, 88 in Europe, and 73 in other regions. Broad representation was achieved with respect to staff role, years of experience, and clinic ownership. Most (71%) respondents reported being aware of the 2023 consensus statement. While the majority (77%-83%, depending on device type) reported using hybrid in-person and remote management for patients with therapeutic CIEDs, 89% to 91% reported scheduling routine office visits at least once per year, depending on device type, respectively. Only 50% of respondents reported a hybrid approach for insertable cardiac monitor patients, with 35% reporting remote-only follow-up. Conclusion: Variable adoption was found for many practices recommended in the 2023 Heart Rhythm Society/European Heart Rhythm Association/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society consensus. Future research should focus on optimal implementation of recommended practices.

Indexed as

Cardiovascular implantable electronic deviceEfficiencyPatient managementQuality improvementRemote monitoringSurvey

Identifiers

PMID40717857
PMCPMC12287964

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.